BioCentury | Jul 16, 2009
Distillery Therapeutics

Indication: Neurology

...BZRAP1); MAM domain containing glycosylphosphatidylinositol anchor 2 (MDGA2); contactin 4 (CNTN4); neurexin 1 (NRXN1) A genomewide study suggests that BZRAP1 and MDGA2...
...encodes a neuronal cell-adhesion protein previously identified as a potential risk locus, and deletions in MDGA2...
Items per page:
1 - 1 of 1